UBS Group Analysts Give Fresenius SE & Co KGaA (FRE) a €59.00 Price Target

UBS Group set a €59.00 ($70.24) price target on Fresenius SE & Co KGaA (FRA:FRE) in a report issued on Friday, www.boersen-zeitung.de reports. The brokerage currently has a sell rating on the stock.

FRE has been the topic of a number of other reports. Morgan Stanley set a €83.00 ($98.81) price target on Fresenius SE & Co KGaA and gave the stock a buy rating in a report on Wednesday, October 4th. Kepler Capital Markets set a €63.00 ($75.00) price target on Fresenius SE & Co KGaA and gave the stock a neutral rating in a report on Tuesday, November 28th. Warburg Research set a €80.00 ($95.24) price target on Fresenius SE & Co KGaA and gave the stock a buy rating in a report on Thursday, December 21st. Goldman Sachs Group set a €78.00 ($92.86) price target on Fresenius SE & Co KGaA and gave the stock a neutral rating in a report on Thursday, October 5th. Finally, Oddo Bhf set a €82.00 ($97.62) price target on Fresenius SE & Co KGaA and gave the stock a buy rating in a report on Monday, October 23rd. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and eleven have issued a buy rating to the company’s stock. The company has a consensus rating of Buy and an average target price of €78.66 ($93.65).

Fresenius SE & Co KGaA (FRA:FRE) opened at €67.06 ($79.83) on Friday. Fresenius SE & Co KGaA has a twelve month low of €60.16 ($71.62) and a twelve month high of €80.00 ($95.24). The company has a market capitalization of $37,040.00 and a P/E ratio of 21.36.

ILLEGAL ACTIVITY NOTICE: This article was originally posted by Community Financial News and is owned by of Community Financial News. If you are viewing this article on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this article can be viewed at https://www.com-unik.info/2018/01/08/ubs-group-analysts-give-fresenius-se-59-00-price-target.html.

About Fresenius SE & Co KGaA

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

What are top analysts saying about Fresenius SE & Co KGaA? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Fresenius SE & Co KGaA and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit